ALS News Today Home | ALS News Today
3 days ago · Diabetes, high cholesterol linked with lower risk of developing ALS. People with diabetes or high cholesterol may be less likely to develop amyotrophic lateral sclerosis (ALS) …
MN-166 (ibudilast) slowing ALS progression, early trial data suggest
Dec 10, 2024 · Results of the analysis were presented at the 35th International Symposium on ALS/MND, held Dec. 6-8 in Montreal. The presentation was titled “ COMBAT-ALS Phase 2b/3 …
Top 10 ALS news stories of 2024
Dec 30, 2024 · Read this story here. No. 8 – COYA 302 immune-modulating therapy shows promise in small early trial. Coya Therapeutics’ investigational therapy COYA 302 was found …
How I made my own resilience checklist to live with ALS
Dec 11, 2024 · That was something I noticed happening to patients in my own ALS community.Some were mentally stuck in what I call the ALS waiting room, while others …
Brain scans may predict ALS risk in C9ORF72 mutation carriers
Nov 29, 2024 · The findings suggest that looking for changes in brain structures could help predict which people with C9ORF72 mutations will develop ALS.. The study, “ Longitudinal Magnetic …
AcuraStem receives $4M grant to advance ASO treatment for ALS
Sep 11, 2024 · AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the development of AS-241, an investigational …
Trace Neuroscience launches, aims to develop treatment for ALS
Nov 15, 2024 · Trace Neuroscience kicked off its operations in California with $101 million in Series A financing, which the company will use to continue developing its lead treatment …
Mayo Clinic granted $22M to study ibudilast in ALS patient program
Sep 30, 2024 · ALS is a progressive neurological disorder marked by dysfunction and death of motor neurons, the specialized nerve cells that facilitate movement, speaking, swallowing, and …
FDA outlines steps to consider accelerated approval of CNM-Au8
Dec 11, 2024 · The therapy’s developer, Clene, said it will put together an application in the coming months, with the goal of submitting it in mid-2025. “We are incredibly grateful for the …
Neuvivo requests FDA approval of ALS treatment NP001
Oct 9, 2024 · The new drug application comes on the heels of combined data from Phase 2a (NCT01281631) and Phase 2b (NCT02794857) clinical trials, in which NP001 slowed disease …